MENU

TRIB Stock Trinity Biotech (TRIB, $0.93) Stochastic Oscillator left the oversold zone on February 03, 2025

A.I.dvisor
at Tickeron.com
Loading...
TRIB - Trinity Biotech plc
Stochastic signal
Bullish Trend
Odds of UP Trend
Tickeron
Stochastic signal
Price: $0.925
Daily change: +$0.025 (+2.78%)
Daily volume: 418.9K
Capitalization: $25.5M
Industry: Medical Specialties
This is a signal that TRIB's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options. A.I.dvisor identified 62 similar cases where TRIB's stochastic oscillator exited the oversold zone, and of them led to successful outcomes. Odds of Success:

TRIB in +3.33% Uptrend, advancing for three consecutive days on February 04, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TRIB advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The 10-day RSI Indicator for TRIB moved out of overbought territory on January 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on February 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TRIB as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TRIB turned negative on February 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

TRIB moved below its 50-day moving average on January 30, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TRIB crossed bearishly below the 50-day moving average on February 12, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRIB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TRIB broke above its upper Bollinger Band on January 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.112) is normal, around the industry mean (23.448). P/E Ratio (33.003) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.329) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.209) is also within normal values, averaging (41.230).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TRIB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
TRIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a devloper of medical diagnostic products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
IDA Business Park
Phone
+353 12769800
Employees
398
Web
https://www.trinitybiotech.com